Latest Thrombus Stories

PEACHTREE CITY, Ga., Nov. 10, 2010 /PRNewswire/ -- SIGVARIS, the global leader in medical compression therapy, has teamed up with the North American Thrombosis Forum and Boston Red Sox Manager and blood clot survivor, Terry Francona, to raise awareness about the dangers of blood clots. Did you know that every year more people die from blood clots than from breast cancer, AIDS and car accidents combined? That's why SIGVARIS, the global leader in medical compression stockings and socks, is...

The clot-busting drug rt-PA remains the most beneficial proven emergency treatment for strokes caused by blood clots, according to an editorial in the November issue of Archives of Neurology by Dr. José Biller."The benefits of treatment outweigh the risks in patients treated with intravenous rt-PA within 4.5 hours of symptom onset," Biller wrote. Biller is chairman of the Department of Neurology at Loyola University Chicago Stritch School of Medicine and an internationally...

(Ivanhoe Newswire) -- Platelets are cell fragments that circulate in the blood of mammals.  These big, regularly-shaped cells are chiefly involved in hemostasis, a central factor leading to the formation of blood clots.  If the number of platelets is too low, excessive bleeding can occur (thrombocytopenia).  However, if the number of platelets is too high, blood clots can form (thrombosis). Mortimer Poncz and colleagues, at Children's Hospital of Philadelphia, working with mice, have...

LAKEWOOD, Colo., Oct. 27 /PRNewswire-USNewswire/ -- As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a...

SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Atrial fibrillation, which affects more than 2 million Americans, involves very fast and uncoordinated contractions of...

MOUNTAIN VIEW, Calif., Oct. 8 /PRNewswire/ -- Concentric Medical, Inc. today announced the full European launch of Trevo(TM), the first device utilizing Stentriever(TM) technology for clot retrieval in ischemic stroke patients. Trevo is the newest offering in a portfolio of products from Concentric Medical, the company that first introduced retrievers for acute ischemic stroke. The Trevo's stent-like design leverages the company's long history of developing clot retrieval technologies for...

New study identifies risk factors for the complications of a dangerous blood clotRisk factors for venous thromboembolism after total hip replacement (THR) surgery were identified in a new study published in the September 2010 issue of The Journal of Bone and Joint Surgery  (JBJS). While the rate of thromboembolism has been significantly reduced through medication, understanding the risk factors could further reduce the likelihood of patients developing this potentially fatal...

Arming Healthcare Professionals to Stop the Clot® TARRYTOWN, N.Y., Sept. 14 /PRNewswire-USNewswire/ -- The National Blood Clot Alliance (NBCA) is making available an easily accessible, no-cost online curriculum for nurses, nurse practitioners, physician assistants, and pharmacists to help increase understanding about the diagnosis and treatment of blood clots and blood clotting disorders. Access to the curriculum, entitled Stop The Clot®: What Every Healthcare Professional Should...

WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology. VTE, the formation of blood clots in the veins, develops in up to 20 percent of cancer patients and is one of the...

(Ivanhoe Newswire) -- Not brushing your teeth at night may lead to more than just a few cavities.  Some researchers say poor oral hygiene could actually lead to heart disease.They say without regular brushing and flossing, bacteria from plaque can escape into the bloodstream and wreck havoc."Poor dental hygiene can lead to bleeding gums, providing bacteria with an escape route into the bloodstream, where they can initiate blood clots leading to heart disease," Professor Howard...